Judith Outten
Child & Adolescent Psychiatry · Southampton, PANPI 1174546592
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 263 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by AbbVie at 30.8% of the total. Among child & adolescent psychiatry clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 263 payments — averaging $17.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Supernus Pharmaceuticals, Inc.$434
- Neos Therapeutics, LP$336
- Lundbeck LLC$314
- Otsuka America Pharmaceutical, Inc.$274
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$235
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,536100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 104 | $1,401 |
| Supernus Pharmaceuticals, Inc. | 18 | $434 |
| Neos Therapeutics, LP | 17 | $336 |
| Lundbeck LLC | 21 | $314 |
| Otsuka America Pharmaceutical, Inc. | 10 | $274 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $235 |
| Sunovion Pharmaceuticals Inc. | 17 | $224 |
| Johnson & Johnson | 9 | $168 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $159 |
| Corium, LLC | 7 | $153 |
| Ironshore Pharmaceuticals Inc. | 5 | $112 |
| Axsome Therapeutics, Inc. | 5 | $108 |
| Neurocrine Biosciences, Inc. | 4 | $98 |
| Vanda Pharmaceuticals Inc. | 3 | $75 |
| Collegium Pharmaceutical, Inc. | 3 | $57 |
| E.r. Squibb & Sons, L.L.C. | 2 | $54 |
| Shire North American Group Inc | 3 | $53 |
| Almatica Pharma LLC | 2 | $45 |
| Tris Pharma Inc | 3 | $45 |
| Alkermes, Inc. | 2 | $44 |
| Bausch Health US, LLC | 2 | $42 |
| Teva Pharmaceuticals USA, Inc. | 3 | $39 |
| Vertical Pharmaceuticals, LLC | 2 | $32 |
| Adlon Therapeutics L.p. | 2 | $26 |
| Neuronetics, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,543 in reported general payments places this provider in the 90th percentile of 200 child & adolescent psychiatry providers in Pennsylvania.
See all child & adolescent psychiatry providers in Pennsylvania →
Other child & adolescent psychiatry in Southampton
- Razvan TorneaSouthampton$816
- Dennis BorczonErie$120K
- Suzanne LucotCranberry Township$72K
- Dan UdreaWexford$51K
- Robert WilsonErie$34K
- Craig FeasterState College$18K
- Thomas WindPhiladelphia$17K
- Laura AdangPhiladelphia$15K
- Christoph LamPhiladelphia$13K
- Raman BawejaHershey$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.